Multi-drug resistant hyperprolactinaemia - a rarity or a rising entity?
نویسندگان
چکیده
منابع مشابه
اثر مهاری عصاره سیر براسترپتوکوک موتانس مقاوم چند دارویی (multi-drug resistant)
چکیده ندارد.
15 صفحه اولSynergy of a Novel Antibiotic Adjuvant Entity against Multi Drug Resistant Enterobacteriaceae
In the present investigation, we investigated the in vitro interaction of ceftriaxone plus sulbactam with disodium edetate, a Non Antibiotic Adjuvant (NAA) against selected clinical isolates and in vitro susceptibility studies were also performed. The isolates were tested against a range of ratios of ceftriaxone and sulbactam using a microdilution checkerboard method. Having determined the appr...
متن کاملA challenging entity: multiple sclerosis or collagen tissue disorders: A case series of 6 patients
Background: Multiple sclerosis and other demyelinating processes are sometimes difficult to differentiate from the neurological involvement in autoimmune diseases. Distinguishing multiple sclerosis from other lesions due to autoimmune diseases is crucial to avoid unsuitable or delayed treatments. Methods: Charts of 6 patients diagnosed with mimicking multiple sclerosis between 1996 and 2014 we...
متن کاملMulti-drug Resistant Citrobacter freundii Isolates in a Burn Hospital in Northeast of Iran: A Single-Center Cross-sectional Study
Background: Multi-drug resistant (MDR) Citrobacter freundii (C. freundii) as a causative agent of nosocomial infections is a health threat, especially in hospitals. This study was conducted to determine the prevalence of MDR C. freundii, considering isolation sites and a variety of utilized antibiotics. Materials and Methods: In this cross-sectional study, the clinical samples of C. freundii s...
متن کاملManagement of Multi-Drug Resistant Methicillin Resistant Staphylococcus aureus Induced Pneumonia with New Antibiotic Adjuvant Entity: A Retrospective Study
Aim/Objective: Increase in incidences of pneumonia due to multi-drug resistant methicillin resistant Staphylococcus aureus (MRSA) in both community and health care settings is of great concern globally. Present study aims to retrospectively analyze the efficacy of new fixed dose combination with antibiotic adjuvant entity (FDC) in comparison with vancomycin to treat patients with multidrug resi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Endocrine Abstracts
سال: 2017
ISSN: 1479-6848
DOI: 10.1530/endoabs.50.ep072